Differences

This shows you the differences between two versions of the page.

--- national_advisory_committee_on_immunization [2023/04/19 22:34]
liam
+++ national_advisory_committee_on_immunization [2023/04/19 23:20] (current)
liam
@@ Line 14: / Line 14: @@
 On June 29, 2022, NACI issued guidance recommending "booster doses" of [[:COVID-19 vaccines]] for all "Canadians at increased risk of serious illness from [[COVID-19]]", regardless of how many doses they had previously received.((Boynton, S. (2022, June 19). //COVID-19 boosters recommended this fall ahead of future pandemic wave: NACI.// Global News. http://archive.today/2023.04.19-201142/https://globalnews.ca/news/8957899/naci-covid-19-boosters-fall-canada/))
+On March 3, 2023, NACI called for "high-risk individuals" to receive another booster dose in the spring.((National Advisory Committee on Immunization. (2023, March 3). //Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19.// Public Health Agency of Canada. https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-additional-covid-19-booster-dose-spring-2023-individuals-high-risk-severe-illness-due-covid-19/statement.pdf)) ((Pelley, L. (2023, March 3). //COVID-19 booster shots recommended for high-risk Canadians starting this spring.// CBC News. https://web.archive.org/web/20230419211957/https://www.cbc.ca/news/health/covid-booster-recommendations-1.6767057))
 ===== Organization =====
@@ Line 71: / Line 73: @@
 | [[Jennifer Pennock]]  | Ex-officio representative for the Surveillance and Epidemiology Division of the [[Centre for Immunization and Respiratory Infectious Diseases]] (CIRID) at [[Public Health Agency of Canada]]  | -  |
 | [[Robert Pless]]  | Ex-officio representative for the [[Biologics and Genetic Therapies Directorate]] at [[Health Canada]]  | -  |
-===== External links =====